The development of radiopharmaceuticals for imaging and therapy has become a major focus in the field of cancer treatment. Bifunctional chelators (BFCs) attach to bioconjugates that allow for targeted radiation. This thesis examines the hydroxamate-based (hydroxamic acid) ligands for hard radiometal ions, such as zirconium-89. The current gold standard for ⁸⁹Zr⁴⁺ complexation is the chelating siderophore, desferrioxamine, a hexadentate ligand that has been shown to have stability issues for complexation with ⁸⁹Zr⁴⁺. New hydroxamate ligands have shown that flexibility is an issue for having four arms bind to ⁸⁹Zr⁴⁺. The potentially octadentate, hydroxamate-based ligand, H₄octaha (1), was designed to overcome the flexibility issue. The synth...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
New bifunctional hexa- and octadentate analogues of the hydroxamate-containing siderophore desferric...
The development of radiopharmaceuticals for imaging and therapy has become a major focus in the fiel...
Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in ...
Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in ...
International audienceSingle crystal X-ray diffraction shows that Zr(IV) forms an octa-coordinated c...
Advances in nuclear medicine include new chelating ligands that form highly stable and kinetically i...
The successful application of radiometals for diagnosis and therapy in nuclear medicine requires che...
International audienceNuclear medicine has seen impressive growth in recent years. An important deve...
Current directions in radiochemistry and nuclear medicine highlight the importance of Positron Emiss...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
The development of bifunctional chelators (BFCs) for zirconium-89 immuno-PET applications is an area...
Metal-based radiopharmaceuticals are critical in nuclear medicine for non-invasive diagnosis and tre...
Increasing attention has been recently devoted to 89Zr(IV) and 68Ga(III) radionuclides, due to their...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
New bifunctional hexa- and octadentate analogues of the hydroxamate-containing siderophore desferric...
The development of radiopharmaceuticals for imaging and therapy has become a major focus in the fiel...
Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in ...
Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in ...
International audienceSingle crystal X-ray diffraction shows that Zr(IV) forms an octa-coordinated c...
Advances in nuclear medicine include new chelating ligands that form highly stable and kinetically i...
The successful application of radiometals for diagnosis and therapy in nuclear medicine requires che...
International audienceNuclear medicine has seen impressive growth in recent years. An important deve...
Current directions in radiochemistry and nuclear medicine highlight the importance of Positron Emiss...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
The development of bifunctional chelators (BFCs) for zirconium-89 immuno-PET applications is an area...
Metal-based radiopharmaceuticals are critical in nuclear medicine for non-invasive diagnosis and tre...
Increasing attention has been recently devoted to 89Zr(IV) and 68Ga(III) radionuclides, due to their...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
(89)Zr-based imaging agents hold great promise as novel radio-tracers in nuclear medicine. However, ...
New bifunctional hexa- and octadentate analogues of the hydroxamate-containing siderophore desferric...